Increased HLA-DR expression and cortical demyelination in MS links with HLA-DR15

Lukas Simon Enz1, Thomas Zeis1, Daniela Schmid1

  • 1From the Neurobiology (L.S.E., T.Z., D.S., N.S.-W.), Department of Biomedicine, University Hospital Basel, University Basel, Zentrum für Lehre und Forschung, Switzerland; Department of Biomedicine (F.G.), Bioinformatics Core Facility, University Hospital Basel, Switzerland; SIB Swiss Institute of Bioinformatics (F.G.), Basel, Switzerland; Institute of Neuropathology (F.v.d.M., C.S.), University Medical Center, Göttingen, Germany; Roche Pharma Research and Early Development (pRED) (G.S., U.C.), Roche Innovation Center Basel, Switzerland; Institute of Clinical Transfusion Medicine (T.M.C.B.), Hospital Braunschweig, Germany; and Neuroimmunology and MS Research (R.M.), Neurology Clinic, University Hospital Zurich, University Zurich, Switzerland.

Summary

High expression of HLA-DRB1 and HLA-DRB5 in multiple sclerosis (MS) normal-appearing gray matter is linked to the MS-associated HLA-DR15 haplotype and increased cortical lesion size.